国产恩替卡韦治疗乙型肝炎肝硬化患者52周疗效分析

doi:10.3969/j.issn.1672-5069.2016.06.024

Abstract

Zhang Hongling, Quan Haiyan, Lin Meihua, et al.. Domestic entecavir 52 week treatment for patients with hepatitis B cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 726-727.

[1] 钟敬波.抗乙型肝炎病毒核苷类药物的研究进展.中国热带医学，2007，7:2114-2133.
[2] Furusyo N，Shimizu M，Oqawa E，et al. Hepatitis B virus infection:current trends and issues. Rinsho Bvori，2015，63（6）:755-761.
[3] Seo Y，Yano Y. Short- and long-term outcome of interferon therapy for chronic hepatitis B infection. World J Gastroenterol，2014，20（37）:13284-13292.
[4] 黄英男，吴昊，沈锡中.乙型肝炎肝硬化抗病毒治疗研究进展.复旦学报（医学版），2013，40:233-238.
[5] 中华医学会感染病学分会，中华医学会感病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志，2011，14（2）:81-89.
[6] 科技部十二五重大专项联合课题组专家.乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理.传染病信息，2014，27（2） :148-150.
[7] 王用兵，艾池波.失代偿期乙肝肝硬化患者核苷类抗病毒药物远期疗效分析.检验医学与临床，2015，12（23）:3525-3527.
[8] 王宇，贾继东.Fibroscan评价肝纤维化进程.肝脏，2007，12:336-338.
[9] 贾继东，尹珊珊.肝纤维化诊断和治疗进展.临床内科杂志，2002，19:244-246.
[10] 于吉广，邹志强，丁玉平. 无创肝纤维化检测与肝脏穿刺病理诊断的对照研究进展.实用临床医药杂志，2011，15:118-121.
[11] 关翠英，阿娜尔古丽·穆哈买尔. 替比夫定和恩替卡韦治疗代偿期乙型肝炎肝硬化的临床疗效分析. 中医药指南，2015，13:153.
[12] 王荣琦，任伟光，赵素贤，等. 瞬时弹性成像技术与多参数模型评估慢性肝病肝纤维化程度的临床研究.中华肝脏病杂志，2015，23（4）:265-269.
[13] 宋乐，姜晓静.瞬时弹性检测技术在肝脏疾病诊断中的应用.实用肝脏病杂志，2016，19（1）:102-104.

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[6]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[7]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[8]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[9]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[10]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[11]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[12]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[13]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[14]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[15]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.

Domestic entecavir 52 week treatment for patients with hepatitis B cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments